{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:30:56Z","timestamp":1775809856014,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DIR, NIAID, NIH"},{"name":"Public Heath Agency of Canada internal funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne pathogen causing a febrile illness in humans, which can progress to hemorrhagic manifestations, multi-organ failure, and death. Current mouse models of CCHFV infection reliably succumb to virus challenge but vary in their ability to reflect signs of disease similar to humans. In this study, we established a signal transducer and activator of transcription 2 (<jats:italic>STAT<\/jats:italic>2) knockout hamster model to expand the repertoire of animal models of CCHFV pathogenesis that can be used for therapeutic development. These hamsters demonstrated a systemic and lethal disease in response to infection. Hallmarks of human disease were observed including petechial rash, blood coagulation dysfunction, and various biochemistry and blood cell count abnormalities. Furthermore, we also demonstrated the utility of this model for anti-CCHFV therapeutic evaluation. The STAT2 knock-out hamster model of CCHFV infection may provide some further insights into clinical disease, viral pathogenesis, and pave the way for testing of potential drug and vaccine candidates.<\/jats:p>","DOI":"10.1038\/s41598-020-69054-3","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:05:06Z","timestamp":1595498706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis"],"prefix":"10.1038","volume":"10","author":[{"given":"Charlene","family":"Ranadheera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emelissa J.","family":"Valcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce M.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Poliquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Rosenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Saturday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna B.","family":"Westover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian B.","family":"Gowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongde","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Safronetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"69054_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","volume":"64","author":"CA Whitehouse","year":"2004","unstructured":"Whitehouse, C. A. Crimean-congo hemorrhagic fever. Antiviral Res. 64, 145\u2013160 (2004).","journal-title":"Antiviral Res."},{"key":"69054_CR2","first-page":"722","volume":"68","author":"JR Joubert","year":"1985","unstructured":"Joubert, J. R., King, J. B., Rossouw, D. J. & Cooper, R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S. Afr. Med. J. 68, 722\u2013728 (1985).","journal-title":"S. Afr. Med. J."},{"issue":"Suppl 4","key":"69054_CR3","doi-asserted-by":"publisher","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","volume":"11","author":"R Swanepoel","year":"1989","unstructured":"Swanepoel, R. et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11(Suppl 4), S794-800 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"69054_CR4","first-page":"839","volume":"121","author":"FJ Burt","year":"1997","unstructured":"Burt, F. J. et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121, 839\u2013846 (1997).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"69054_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7883\/yoken.64.439","volume":"64","author":"A Kubar","year":"2011","unstructured":"Kubar, A. et al. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn. J. Infect. Dis. 64, 439\u2013443 (2011).","journal-title":"Jpn. J. Infect. Dis."},{"key":"69054_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4269\/ajtmh.1996.55.190","volume":"55","author":"TF Schwarz","year":"1996","unstructured":"Schwarz, T. F. et al. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am. J. Trop. Med. Hyg. 55, 190\u2013196 (1996).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"69054_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6, 203\u2013214 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"69054_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4066\/AMJ.2011.701","volume":"4","author":"R Verma","year":"2011","unstructured":"Verma, R., Khanna, P., Prinja, S. & Rajput, M. Crimean-Congo haemorrhagic fever: An outbreak in India. Australas. Med. J. 4, 589\u2013591 (2011).","journal-title":"Australas. Med. J."},{"key":"69054_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ijid.2009.03.028","volume":"13","author":"RM Vorou","year":"2009","unstructured":"Vorou, R. M. Crimean-Congo hemorrhagic fever in southeastern Europe. Int. J. Infect. Dis. 13, 659\u2013662 (2009).","journal-title":"Int. J. Infect. Dis."},{"key":"69054_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","volume":"78","author":"O Ergonul","year":"2008","unstructured":"Ergonul, O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 78, 125\u2013131 (2008).","journal-title":"Antiviral Res."},{"key":"69054_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jac\/dkr136","volume":"66","author":"S Ascioglu","year":"2011","unstructured":"Ascioglu, S., Leblebicioglu, H., Vahaboglu, H. & Chan, K. A. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J. Antimicrob. Chemother. 66, 1215\u20131222 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"69054_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jinf.2009.01.014","volume":"58","author":"N Elaldi","year":"2009","unstructured":"Elaldi, N. et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect. 58, 238\u2013244 (2009).","journal-title":"J. Infect."},{"key":"69054_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","volume":"346","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch, S. P. et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346, 472\u2013475 (1995).","journal-title":"Lancet"},{"key":"69054_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","volume":"12","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O., Celikbas, A., Baykam, N., Eren, S. & Dokuzoguz, B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin. Microbiol. Infect. 12, 551\u2013554 (2006).","journal-title":"Clin. Microbiol. Infect."},{"key":"69054_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jmv.24864","volume":"89","author":"O Ergonul","year":"2017","unstructured":"Ergonul, O. et al. Cytokine response in crimean-congo hemorrhagic fever virus infection. J. Med. Virol. 89, 1707\u20131713 (2017).","journal-title":"J. Med. Virol."},{"key":"69054_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijid.2007.09.010","volume":"12","author":"MA Cevik","year":"2008","unstructured":"Cevik, M. A. et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int. J. Infect. Dis. 12, 374\u2013379 (2008).","journal-title":"Int. J. Infect. Dis."},{"key":"69054_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/1471-2334-14-416","volume":"14","author":"S Kaya","year":"2014","unstructured":"Kaya, S. et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect. Dis. 14, 416\u20132334 (2014).","journal-title":"BMC Infect. Dis."},{"key":"69054_CR18","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.ijid.2011.06.005","volume":"16","author":"B Ozturk","year":"2012","unstructured":"Ozturk, B. et al. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int. J. Infect. Dis. 16, e89-93 (2012).","journal-title":"Int. J. Infect. Dis."},{"key":"69054_CR19","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1086\/521244","volume":"45","author":"MA Cevik","year":"2007","unstructured":"Cevik, M. A. et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 45, e96-100 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"69054_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jcla.20383","volume":"24","author":"P Onguru","year":"2010","unstructured":"Onguru, P. et al. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J. Clin. Lab. Anal. 24, 163\u2013166 (2010).","journal-title":"J. Clin. Lab. Anal."},{"key":"69054_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cytogfr.2008.11.001","volume":"19","author":"F Weber","year":"2008","unstructured":"Weber, F. & Mirazimi, A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19, 395\u2013404 (2008).","journal-title":"Cytokine Growth Factor Rev."},{"key":"69054_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1128\/CVI.00530-09","volume":"17","author":"A Saksida","year":"2010","unstructured":"Saksida, A. et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin. Vaccine Immunol. 17, 1086\u20131093 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"69054_CR23","first-page":"742","volume":"32","author":"M Yesilyurt","year":"2011","unstructured":"Yesilyurt, M. et al. The early prediction of fatality in Crimean Congo hemorrhagic fever patients. Saudi Med. J. 32, 742\u2013743 (2011).","journal-title":"Saudi Med. J."},{"key":"69054_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcv.2010.01.010","volume":"47","author":"G Yilmaz","year":"2010","unstructured":"Yilmaz, G., Koksal, I., Topbas, M., Yilmaz, H. & Aksoy, F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J. Clin. Virol. 47, 361\u2013365 (2010).","journal-title":"J. Clin. Virol."},{"key":"69054_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/500836","volume":"193","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O., Tuncbilek, S., Baykam, N., Celikbas, A. & Dokuzoguz, B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193, 941\u2013944 (2006).","journal-title":"J. Infect. Dis."},{"key":"69054_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcv.2006.04.007","volume":"36","author":"A Papa","year":"2006","unstructured":"Papa, A. et al. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36, 272\u2013276 (2006).","journal-title":"J. Clin. Virol."},{"key":"69054_CR27","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3201\/eid1311.070222","volume":"13","author":"D Duh","year":"2007","unstructured":"Duh, D. et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13, 1769\u20131772 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"69054_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3201\/eid1307.070068","volume":"13","author":"R Wolfel","year":"2007","unstructured":"Wolfel, R. et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 13, 1097\u20131100 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"69054_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3201\/eid1305.061588","volume":"13","author":"A Papa","year":"2007","unstructured":"Papa, A. et al. Viral load and Crimean-Congo hemorrhagic fever. Emerg. Infect. Dis. 13, 805\u2013806 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"69054_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41564-018-0141-7","volume":"3","author":"E Haddock","year":"2018","unstructured":"Haddock, E. et al. A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. Nat. Microbiol. 3, 556\u2013562 (2018).","journal-title":"Nat. Microbiol."},{"key":"69054_CR31","doi-asserted-by":"publisher","first-page":"11089","DOI":"10.1128\/JVI.01383-10","volume":"84","author":"DA Bente","year":"2010","unstructured":"Bente, D. A. et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089\u201311100 (2010).","journal-title":"J. Virol."},{"key":"69054_CR32","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","volume":"91","author":"S Bereczky","year":"2010","unstructured":"Bereczky, S. et al. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 91, 1473\u20131477 (2010).","journal-title":"J. Gen. Virol."},{"key":"69054_CR33","doi-asserted-by":"publisher","first-page":"e2804","DOI":"10.1371\/journal.pntd.0002804","volume":"8","author":"L Oestereich","year":"2014","unstructured":"Oestereich, L. et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop. Dis. 8, e2804 (2014).","journal-title":"PLoS Negl Trop. Dis."},{"key":"69054_CR34","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/infdis\/jit061","volume":"207","author":"M Zivcec","year":"2013","unstructured":"Zivcec, M. et al. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha\/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J. Infect. Dis. 207, 1909\u20131921 (2013).","journal-title":"J. Infect. Dis."},{"key":"69054_CR35","doi-asserted-by":"publisher","first-page":"01083","DOI":"10.1128\/JVI.01083-18.Print2018Nov1","volume":"92","author":"ME Lindquist","year":"2018","unstructured":"Lindquist, M. E. et al. Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type i interferon blockade in mice. J. Virol. 92, 01083. https:\/\/doi.org\/10.1128\/JVI.01083-18.Print2018Nov1 (2018).","journal-title":"J. Virol."},{"key":"69054_CR36","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/infdis\/jix215","volume":"216","author":"JR Spengler","year":"2017","unstructured":"Spengler, J. R. et al. Crimean-Congo hemorrhagic fever in humanized mice reveals glial cells as primary targets of neurological infection. J. Infect. Dis. 216, 1386\u20131397 (2017).","journal-title":"J. Infect. Dis."},{"key":"69054_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.virol.2017.04.013","volume":"507","author":"V Siddharthan","year":"2017","unstructured":"Siddharthan, V. et al. Zika virus infection of adult and fetal STAT2 knock-out hamsters. Virology 507, 89\u201395 (2017).","journal-title":"Virology"},{"key":"69054_CR38","doi-asserted-by":"publisher","first-page":"e1005084","DOI":"10.1371\/journal.ppat.1005084","volume":"11","author":"K Toth","year":"2015","unstructured":"Toth, K. et al. STAT2 knockout syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control. PLoS Pathog. 11, e1005084 (2015).","journal-title":"PLoS Pathog."},{"key":"69054_CR39","doi-asserted-by":"publisher","first-page":"e01942","DOI":"10.1128\/JVI.01942-16.Print2017Feb1","volume":"91","author":"BB Gowen","year":"2017","unstructured":"Gowen, B. B. et al. Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: importance of STAT2 in preventing disease and effective treatment with favipiravir. J. Virol. 91, e01942. https:\/\/doi.org\/10.1128\/JVI.01942-16.Print2017Feb1 (2017).","journal-title":"J. Virol."},{"key":"69054_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2017.08.004","volume":"511","author":"JB Westover","year":"2017","unstructured":"Westover, J. B. et al. Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir. Virology 511, 175\u2013183 (2017).","journal-title":"Virology"},{"key":"69054_CR41","doi-asserted-by":"publisher","first-page":"e109755","DOI":"10.1371\/journal.pone.0109755","volume":"9","author":"Z Fan","year":"2014","unstructured":"Fan, Z. et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system. PLoS ONE 9, e109755 (2014).","journal-title":"PLoS ONE"},{"key":"69054_CR42","first-page":"227","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman, C. The method of \u201cright and wrong cases\u201d ('constant stimuli\u2019) without Gauss\u2019s formulae. Brit. J. Psychol. 2, 227 (1908).","journal-title":"Brit. J. Psychol."},{"key":"69054_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/QCO.0b013e3282a56a0a","volume":"20","author":"R Vorou","year":"2007","unstructured":"Vorou, R., Pierroutsakos, I. N. & Maltezou, H. C. Crimean-Congo hemorrhagic fever. Curr. Opin. Infect. Dis. 20, 495\u2013500 (2007).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"69054_CR44","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"69054_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/pathogens2020402","volume":"2","author":"M Zivcec","year":"2013","unstructured":"Zivcec, M., Safronetz, D. & Feldmann, H. Animal models of tick-borne hemorrhagic Fever viruses. Pathogens 2, 402\u2013421 (2013).","journal-title":"Pathogens"},{"key":"69054_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/v11070590","volume":"11","author":"AR Garrison","year":"2019","unstructured":"Garrison, A. R., Smith, D. R. & Golden, J. W. Animal models for Crimean-Congo hemorrhagic fever human disease. Viruses 11, 590. https:\/\/doi.org\/10.3390\/v11070590 (2019).","journal-title":"Viruses"},{"key":"69054_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","volume":"100","author":"DA Bente","year":"2013","unstructured":"Bente, D. A. et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 100, 159\u2013189 (2013).","journal-title":"Antiviral Res."},{"key":"69054_CR48","volume-title":"Data from studying etiology, laboratory diagnosis, and immunology of Crimean hemorrhagic fever; questions of ecology of the viral agent [in Russian] (in English: NAMRU3-T1152)","author":"A Butenko","year":"1971","unstructured":"Butenko, A. Data from studying etiology, laboratory diagnosis, and immunology of Crimean hemorrhagic fever; questions of ecology of the viral agent [in Russian] (in English: NAMRU3-T1152) (Inst Polio Virus Entsef, Akad Med Nauk SSSR Moskva, 1971)."},{"key":"69054_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3201\/eid2101.141413","volume":"21","author":"NG Conger","year":"2015","unstructured":"Conger, N. G. et al. Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerg. Infect. Dis. 21, 23\u201331 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"69054_CR50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3201\/eid2207.151782","volume":"22","author":"AS Kleib","year":"2016","unstructured":"Kleib, A. S. et al. Crimean-Congo Hemorrhagic Fever with Acute Subdural Hematoma, Mauritania, 2012. Emerg. Infect. Dis. 22, 1305\u20131306 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"69054_CR51","unstructured":"Grashchenkov, N. Investigations of etiology, pathogenesis, and clinical symptomatology of Crimean hemorrhagic fever [in Russian] (in English: NAMRU3-T1189). Reports 1944 Sci Investig Inst Neurol Akad Med Nauk SSSR Moskova, 100 (1945)."},{"key":"69054_CR52","first-page":"92","volume":"5","author":"M Neklyudov","year":"1952","unstructured":"Neklyudov, M. A case of hemorrhagic fever (Crimea) [in Russian] (in English: NAMRU3-T1514). Suvrem Med Sof 5, 92 (1952).","journal-title":"Suvrem Med Sof"},{"key":"69054_CR53","unstructured":"Smorodintsev, A., Kazbintsev, L. & Chudakov, V. Virus hemorrhagic fevers [in Russian]. Isreal Progam for Scientific Translations, Jerusalem, 2 (1963)."},{"key":"69054_CR54","doi-asserted-by":"publisher","first-page":"e41365","DOI":"10.1371\/journal.pone.0041365","volume":"7","author":"B Deng","year":"2012","unstructured":"Deng, B. et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS ONE 7, e41365 (2012).","journal-title":"PLoS ONE"},{"key":"69054_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cll.2010.01.001","volume":"30","author":"CL Gardner","year":"2010","unstructured":"Gardner, C. L. & Ryman, K. D. Yellow fever: a reemerging threat. Clin. Lab. Med. 30, 237\u2013260 (2010).","journal-title":"Clin. Lab. Med."},{"key":"69054_CR56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","volume":"371","author":"EA Gould","year":"2008","unstructured":"Gould, E. A. & Solomon, T. Pathogenic flaviviruses. Lancet 371, 500\u2013509 (2008).","journal-title":"Lancet"},{"key":"69054_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","volume":"78","author":"SH Khan","year":"2008","unstructured":"Khan, S. H. et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res. 78, 103\u2013115 (2008).","journal-title":"Antiviral Res."},{"issue":"Suppl 3","key":"69054_CR58","doi-asserted-by":"publisher","first-page":"S810","DOI":"10.1093\/infdis\/jir299","volume":"204","author":"MG Kortepeter","year":"2011","unstructured":"Kortepeter, M. G., Bausch, D. G. & Bray, M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J. Infect. Dis. 204(Suppl 3), S810\u2013S816 (2011).","journal-title":"J. Infect. Dis."},{"key":"69054_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/PCC.0b013e3181e911a7","volume":"12","author":"S Ranjit","year":"2011","unstructured":"Ranjit, S. & Kissoon, N. Dengue hemorrhagic fever and shock syndromes. Pediatr. Crit. Care. Med. 12, 90\u2013100 (2011).","journal-title":"Pediatr. Crit. Care. Med."},{"key":"69054_CR60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/0161-5890(93)90008-Y","volume":"30","author":"Z Vegh","year":"1993","unstructured":"Vegh, Z., Wang, P., Vanky, F. & Klein, E. Increased expression of MHC class I molecules on human cells after short time IFN-gamma treatment. Mol. Immunol. 30, 849\u2013854 (1993).","journal-title":"Mol. Immunol."},{"key":"69054_CR61","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/jcp.37.10.1140","volume":"37","author":"EH Cooper","year":"1984","unstructured":"Cooper, E. H., Forbes, M. A. & Hambling, M. H. Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J. Clin. Pathol. 37, 1140\u20131143 (1984).","journal-title":"J. Clin. Pathol."},{"key":"69054_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2018.06.013","volume":"157","author":"DW Hawman","year":"2018","unstructured":"Hawman, D. W. et al. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Res. 157, 18\u201326 (2018).","journal-title":"Antiviral Res."},{"key":"69054_CR63","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1086\/375058","volume":"36","author":"M Mardani","year":"2003","unstructured":"Mardani, M., Jahromi, M. K., Naieni, K. H. & Zeinali, M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin. Infect. Dis. 36, 1613\u20131618 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"69054_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/422000","volume":"39","author":"O Ergonul","year":"2004","unstructured":"Ergonul, O. et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39, 284\u2013287 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"69054_CR65","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/vbz.2013.1421","volume":"14","author":"SB Ozbey","year":"2014","unstructured":"Ozbey, S. B., Kader, C., Erbay, A. & Ergonul, O. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 14, 300\u2013302 (2014).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"69054_CR66","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/cid\/cit527","volume":"57","author":"B Dokuzoguz","year":"2013","unstructured":"Dokuzoguz, B. et al. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin. Infect. Dis. 57, 1270\u20131274 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"69054_CR67","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/j.ijid.2013.02.030","volume":"17","author":"B Ceylan","year":"2013","unstructured":"Ceylan, B., Calica, A., Ak, O., Akkoyunlu, Y. & Turhan, V. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience. Int. J. Infect. Dis. 17, e799-801 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"69054_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcv.2009.11.007","volume":"47","author":"I Koksal","year":"2010","unstructured":"Koksal, I. et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J. Clin. Virol. 47, 65\u201368 (2010).","journal-title":"J. Clin. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69054-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69054-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:39:02Z","timestamp":1670337542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69054-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69054-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12378"}}